According to Future Market Insight, the global diabetic retinopathy market is likely to reach USD 15.50 billion by 2033, registering a CAGR of 5.8%. This is a significant rise from the estimated value ...
12 天
MedPage Today on MSNCataract Surgery Linked to Increased Risk of Worsening Diabetic RetinopathyCataract surgery was associated with an increased risk of worsening diabetic retinopathy in adults with type 2 diabetes, ...
2 天
HealthDay on MSNGLP-1 Drugs Improve Outlook For Kidney TransplantsGLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...
2 天
Amazon S3 on MSNWhat to Expect After Laser Treatment for Diabetic RetinopathyDr. Amit Gupta, MD, FACS, Ophthalmologist, talks about what to expect after having laser eye treatment for diabetic retinopathy.
He added that while the overall risk of PDR in the study patients was low, "cataracts and diabetic retinopathy are amongst the most common conditions encountered in daily practice. Considering the ...
Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...
New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients ...
If blood sugar goes uncontrolled, diabetes causes progressive damage to structures in the eyes. The ongoing eye damage leads to diabetic eye diseases like retinopathy, cataracts, and glaucoma. People ...
A new study published in the journal of Ophthalmology found cataract surgery to worsen diabetic retinopathy in adults with ...
2 天
News Medical on MSNStudy shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetesKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果